These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 12512085)

  • 1. Site-specific cleavage of the HIV-1 TAR RNA by a hydroxysalen-copper(III) complex.
    Bailly C; Guerniou V; Lamour E; Bernier JL; Villain F; Vezin H
    Chembiochem; 2003 Jan; 4(1):112-4. PubMed ID: 12512085
    [No Abstract]   [Full Text] [Related]  

  • 2. A new type of potent inhibitors of HIV-1 TAR RNA-Tat peptide binding by zinc(II)-macrocyclic tetraamine complexes.
    Kikuta E; Aoki S; Kimura E
    J Am Chem Soc; 2001 Aug; 123(32):7911-2. PubMed ID: 11493067
    [No Abstract]   [Full Text] [Related]  

  • 3. A peptide nucleic acid-neamine conjugate that targets and cleaves HIV-1 TAR RNA inhibits viral replication.
    Riguet E; Tripathi S; Chaubey B; Désiré J; Pandey VN; Décout JL
    J Med Chem; 2004 Sep; 47(20):4806-9. PubMed ID: 15369382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, DNA binding, and cleaving properties of an ellipticine-salen.copper conjugate.
    Routier S; Bernier JL; Catteau JP; Colson P; Houssier C; Rivalle C; Bisagni E; Bailly C
    Bioconjug Chem; 1997; 8(6):789-92. PubMed ID: 9404650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of a dinuclear ruthenium(ii) complex to the TAR region of the HIV-AIDS viral RNA.
    Buck DP; Spillane CB; Collins JG; Keene FR
    Mol Biosyst; 2008 Aug; 4(8):851-4. PubMed ID: 18633486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence correlation spectroscopy at single molecule level on the Tat-TAR complex and its inhibitors.
    Nandi CK; Parui PP; Brutschy B; Scheffer U; Göbel M
    Biopolymers; 2008 Jan; 89(1):17-25. PubMed ID: 17764074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribosomal frameshifting: an emerging drug target for HIV.
    Gareiss PC; Miller BL
    Curr Opin Investig Drugs; 2009 Feb; 10(2):121-8. PubMed ID: 19197789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-phase synthesis and thermal denaturation study of cyclic PNAs targeting the HIV-1 TAR RNA loop.
    Upert G; Mehiri M; Di Giorgio A; Condom R; Patino N
    Bioorg Med Chem Lett; 2007 Nov; 17(21):6026-30. PubMed ID: 17826994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV-1 replication by long-term treatment with a chimeric RNA containing shRNA and TAR decoy RNA.
    Barnor JS; Habu Y; Yamamoto N; Miyano-Kurosaki N; Ishikawa K; Yamamoto N; Takaku H
    Antiviral Res; 2009 Aug; 83(2):156-64. PubMed ID: 19397929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome.
    Westerhout EM; Ooms M; Vink M; Das AT; Berkhout B
    Nucleic Acids Res; 2005; 33(2):796-804. PubMed ID: 15687388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and crystal structure of a salen-type copper(II) complex derived from 3,5'-O-dimethyl-2',3'-diamino-2',3'-dideoxy-beta-D-xylo-uridine.
    Gottschaldt M; Koth D; Görls H
    Org Biomol Chem; 2005 Apr; 3(7):1170-1. PubMed ID: 15785801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha,alpha-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells.
    Wang M; Xu Z; Tu P; Yu X; Xiao S; Yang M
    Bioorg Med Chem Lett; 2004 May; 14(10):2585-8. PubMed ID: 15109657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative DNA cleavage mediated by a new copper (II) terpyridine complex: crystal structure and DNA binding studies.
    Uma V; Kanthimathi M; Weyhermuller T; Nair BU
    J Inorg Biochem; 2005 Dec; 99(12):2299-307. PubMed ID: 16213589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of generation 2-5 of PAMAM dendrimer on the inhibition of Tat peptide/ TAR RNA binding in HIV-1 transcription.
    Wang W; Guo Z; Chen Y; Liu T; Jiang L
    Chem Biol Drug Des; 2006 Dec; 68(6):314-8. PubMed ID: 17177893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mixed-valent ruthenium-oxo oxalato cluster Na7[Ru4(mu3-O)4(C2O4)6] with potent anti-HIV activities.
    Wong EL; Sun RW; Chung NP; Lin CL; Zhu N; Che CM
    J Am Chem Soc; 2006 Apr; 128(15):4938-9. PubMed ID: 16608312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dioxygen activation at a single copper site: structure, bonding, and mechanism of formation of 1:1 Cu-O2 adducts.
    Aboelella NW; Kryatov SV; Gherman BF; Brennessel WW; Young VG; Sarangi R; Rybak-Akimova EV; Hodgson KO; Hedman B; Solomon EI; Cramer CJ; Tolman WB
    J Am Chem Soc; 2004 Dec; 126(51):16896-911. PubMed ID: 15612729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of a neamine dimer targeting the dimerization initiation site of HIV-1 RNA.
    Bodlenner A; Alix A; Weibel JM; Pale P; Ennifar E; Paillart JC; Walter P; Marquet R; Dumas P
    Org Lett; 2007 Oct; 9(22):4415-8. PubMed ID: 17915882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New inhibitors of the Tat-TAR RNA interaction found with a "fuzzy" pharmacophore model.
    Renner S; Ludwig V; Boden O; Scheffer U; Göbel M; Schneider G
    Chembiochem; 2005 Jun; 6(6):1119-25. PubMed ID: 15883975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The design, synthesis, and biological evaluation of novel substituted purines as HIV-1 Tat-TAR inhibitors.
    Yuan D; He M; Pang R; Lin SS; Li Z; Yang M
    Bioorg Med Chem; 2007 Jan; 15(1):265-72. PubMed ID: 17055732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic access to spacer-linked 3,6-diamino-2,3,6-trideoxy-alpha-D-glucopyranosides--potential aminoglycoside mimics for the inhibition of the HIV-1 TAR-RNA/Tat-peptide complex.
    Jöge T; Jesberger M; Bröker P; Kirschning A
    Carbohydr Res; 2007 Sep; 342(12-13):1704-14. PubMed ID: 17562328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.